Comparative Study of the Nucleotide Bias Between the Novel H1N1 and H5N1 Subtypes of Influenza A Viruses Using Bioinformatics Techniques, Journal of Microbiology and Biotechnology, vol.20, pp.63-70, 2010. ,
DOI : 10.4014/jmb.0908.08004
Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection, N. Engl. J. Med, vol.362, pp.1708-1719, 2010. ,
Densitometric analysis of Western blot assays for feline immunodeficiency virus antibodies, Veterinary Immunology and Immunopathology, vol.79, issue.3-4, pp.261-271, 2001. ,
DOI : 10.1016/S0165-2427(01)00265-3
Amplification of the entire genome of influenza A virus H1N1 and H3N2 subtypes by reverse-transcription polymerase chain reaction, Journal of Virological Methods, vol.136, issue.1-2, pp.38-43, 2006. ,
DOI : 10.1016/j.jviromet.2006.03.027
Comparison of a Live Attenuated 2009 H1N1 Vaccine with Seasonal Influenza Vaccines against 2009 Pandemic H1N1 Virus Infection in Mice and Ferrets, Journal of Infectious Diseases, vol.203, issue.7, pp.930-936, 2011. ,
DOI : 10.1093/infdis/jiq144
PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases, Nucleic Acids Research, vol.24, issue.18, p.3546, 1996. ,
DOI : 10.1093/nar/24.18.3546
Influenza Virus Hemagglutinin: A Model for Protein N-Glycosylation in Recombinant <i>Escherichia coli</i>, Intervirology, vol.55, issue.3, pp.219-224, 2011. ,
DOI : 10.1159/000327784
Enhancement of protective humoral immune responses against Herpes simplex virus-2 in DNA-immunized guinea-pigs using protein boosting, FEMS Immunology & Medical Microbiology, vol.54, issue.1, pp.18-26, 2008. ,
DOI : 10.1111/j.1574-695X.2008.00438.x
Baculovirus Expression Systems for Recombinant Protein Production in Insect Cells, Recent Patents on Biotechnology, vol.3, issue.1, pp.46-54, 2009. ,
DOI : 10.2174/187220809787172669
Influenza Pandemics: Past, Present and Future, Journal of the Formosan Medical Association, vol.105, issue.1, pp.1-6, 2006. ,
DOI : 10.1016/S0929-6646(09)60102-9
High frequency of cross-reacting antibodies against 2009 pandemic influenza A (H1N1) virus among the elderly in Finland, Euro Surveill, vol.15, 2010. ,
Subtype identification of the novel A H1N1 and other human influenza A viruses using an oligonucleotide microarray, Archives of Virology, vol.20, issue.10, pp.55-61, 2010. ,
DOI : 10.1007/s00705-009-0545-z
Protection of Mice against Lethal Challenge with 2009 H1N1 Influenza A Virus by 1918-Like and Classical Swine H1N1 Based Vaccines, PLoS Pathogens, vol.76, issue.3, 2010. ,
DOI : 10.1371/journal.ppat.1000745.t005
Spatial, Temporal, and Species Variation in Prevalence of Influenza A Viruses in Wild Migratory Birds, PLoS Pathogens, vol.33, issue.5, p.61, 2007. ,
DOI : 10.1371/journal.ppat.0030061.st002
century, European Journal of Immunology, vol.361, issue.11, pp.2946-2954, 2009. ,
DOI : 10.1002/eji.200939911
URL : https://hal.archives-ouvertes.fr/pasteur-00588921
Molecular Detection of a Novel Human Influenza (H1N1) of Pandemic Potential by Conventional and Real-Time Quantitative RT-PCR Assays, Clinical Chemistry, vol.55, issue.8, p.1555, 2009. ,
DOI : 10.1373/clinchem.2009.130229
URL : https://hal.archives-ouvertes.fr/pasteur-00588929
Virus-Like Particle Vaccine Induces Protective Immunity against Homologous and Heterologous Strains of Influenza Virus, Journal of Virology, vol.81, issue.7, p.3514, 2007. ,
DOI : 10.1128/JVI.02052-06
The early molecular epidemiology of the swine-origin A/H1N1 human influenza pandemic, PLoS Currents, vol.1, p.1003, 2009. ,
DOI : 10.1371/currents.RRN1003
Does Glycosylation as a modifier of Original Antigenic Sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza?, BMC Infectious Diseases, vol.104, issue.4, pp.1-9, 2010. ,
DOI : 10.1093/infdis/151.1.81
Dose???Related Safety and Immunogenicity of Baculovirus???Expressed Trivalent Influenza Vaccine: A Double???Blind, Controlled Trial in Adult Patients with Non???Hodgkin B Cell Lymphoma, The Journal of Infectious Diseases, vol.194, issue.10, p.1394, 2006. ,
DOI : 10.1086/508493
Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005???2009, New England Journal of Medicine, vol.360, issue.25, pp.2616-2625, 2005. ,
DOI : 10.1056/NEJMoa0903812
Receptor Binding and Membrane Fusion in Virus Entry: The Influenza Hemagglutinin, Annual Review of Biochemistry, vol.69, issue.1, pp.531-569, 2000. ,
DOI : 10.1146/annurev.biochem.69.1.531
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic, Nature, vol.22, issue.7250, pp.1122-1125, 2009. ,
DOI : 10.1038/nature08182
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans, Vaccine, vol.19, issue.13-14, pp.1732-1737, 2001. ,
DOI : 10.1016/S0264-410X(00)00395-9
Safety and Immunogenicity of a Baculovirus-Expressed Hemagglutinin Influenza Vaccine, JAMA, vol.297, issue.14, p.1577, 2007. ,
DOI : 10.1001/jama.297.14.1577
The origin of the recent swine influenza A (H1N1) virus infecting humans, Euro Surveill, vol.14, 2009. ,
Rapid Development of an Efficacious Swine Vaccine for Novel H1N1, PLoS Currents, vol.1, 2009. ,
DOI : 10.1371/currents.RRN1123
Evolution and ecology of influenza A viruses, Microbiol. Mol. Biol. Rev, vol.56, pp.152-169, 1992. ,
Structural Basis of Preexisting Immunity to the 2009 H1N1 Pandemic Influenza Virus, Science, vol.328, issue.5976, pp.357-360, 2010. ,
DOI : 10.1126/science.1186430